StemTek Therapeutics Private
StemTek Therapeutics is a biopharmaceutical company based in Bilbao, Spain. Their main focus is on the research and development of drugs for cancer treatment. StemTek utilizes stem cell centric point-of-view technologies for cancer therapy, allowing them to profile their pipeline of compounds for their effect on cancer stem cell populations using 3D culture models. Founded by Angel Martin and Olatz Esnaola, StemTek is dedicated to advancing cancer treatment through innovative drug development.
Industry:
Stem Cells (Regenerative Medicine)
Investors Number:
2
Technology:
Regenerative Medicine
Last Funding Type:
Seed
Headquarters:
Bilbao, Pais Vasco, Spain
Founded Date:
2013-01-01
Investor Type:
For Profit
Funding Status:
Seed
Total Funding:
€50K
Estimated Revenue:
Less than $1M
Employee Number:
10-Jan